Matches in Wikidata for { <http://www.wikidata.org/entity/Q96120346> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- Q96120346 description "2020 ജൂണ് 4 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം" @default.
- Q96120346 description "article scientifique publié en 2020" @default.
- Q96120346 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q96120346 description "im Juni 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q96120346 description "scientific article published on 04 June 2020" @default.
- Q96120346 description "wetenschappelijk artikel" @default.
- Q96120346 description "наукова стаття, опублікована 4 червня 2020" @default.
- Q96120346 name "Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19"" @default.
- Q96120346 name "Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19"" @default.
- Q96120346 type Item @default.
- Q96120346 label "Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19"" @default.
- Q96120346 label "Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19"" @default.
- Q96120346 prefLabel "Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19"" @default.
- Q96120346 prefLabel "Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19"" @default.
- Q96120346 P1433 Q96120346-44A8C64D-B216-4441-A842-75F12F8CC656 @default.
- Q96120346 P1476 Q96120346-9D5083A8-C3B0-4D59-9812-7BD8DF79870C @default.
- Q96120346 P2093 Q96120346-0F4871C6-C7B9-45D3-94E4-816737DA675F @default.
- Q96120346 P2093 Q96120346-2F7A7ACD-CD23-4DC9-8303-76B4A60B4DA4 @default.
- Q96120346 P2093 Q96120346-47009B19-6AFE-4009-B437-0627708F42F4 @default.
- Q96120346 P2093 Q96120346-517B7A8F-25D9-4DC2-9017-DAB292D6C454 @default.
- Q96120346 P2093 Q96120346-69C6B823-6862-49F4-AD97-A290F42CE5BD @default.
- Q96120346 P2093 Q96120346-7689DCE6-5892-4E11-BC56-E23096BE7EC7 @default.
- Q96120346 P2093 Q96120346-9ADE557B-FB70-47C6-BCD5-FC040D8CFF1A @default.
- Q96120346 P2093 Q96120346-A734B1C8-D7F4-49F6-A593-578FF189E5E5 @default.
- Q96120346 P2860 Q96120346-415B9D2A-6767-4D54-82C4-CCEEB19F45A2 @default.
- Q96120346 P2860 Q96120346-45C01986-FBBE-489D-BE34-6524F7D3DF52 @default.
- Q96120346 P2860 Q96120346-5A95E98B-DC98-4A17-A66A-94471A3720C2 @default.
- Q96120346 P2860 Q96120346-64B4B7AA-032F-48C1-814F-0F1FC8CDC682 @default.
- Q96120346 P2860 Q96120346-6C434C60-C1C2-46E2-9CE4-0AD4D9B3FE8A @default.
- Q96120346 P2860 Q96120346-8A56968B-832E-4774-933E-B1CD08F7445E @default.
- Q96120346 P2860 Q96120346-D51CCA85-952D-4B44-A035-FBF34CB5B0BE @default.
- Q96120346 P304 Q96120346-4DCE0DF4-C949-42DB-B841-3538D2FC352F @default.
- Q96120346 P31 Q96120346-BF962B74-C2C9-43A7-BB8B-3C8D1A8F09C0 @default.
- Q96120346 P356 Q96120346-320688B4-2BCF-41BC-A6B9-BBFAC18AA68F @default.
- Q96120346 P433 Q96120346-70436E4E-0C28-4CCF-B398-7000672CFEDE @default.
- Q96120346 P478 Q96120346-8F2E329A-8A7E-4BAD-8A69-E99A3CE88CA5 @default.
- Q96120346 P577 Q96120346-2EA7C913-188D-4C11-9A02-2FA86B246539 @default.
- Q96120346 P698 Q96120346-F374F315-3A74-4709-9ACA-5CA91C15D1D1 @default.
- Q96120346 P921 Q96120346-46B45E0A-4863-4B8E-AC0F-F81185E3C422 @default.
- Q96120346 P932 Q96120346-9CDF7CC5-5FEF-41F7-ACFE-3BA81FC3D4C0 @default.
- Q96120346 P356 CIRCRESAHA.120.317205 @default.
- Q96120346 P698 32496917 @default.
- Q96120346 P1433 Q2599020 @default.
- Q96120346 P1476 "Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19"" @default.
- Q96120346 P2093 "Adam P Bress" @default.
- Q96120346 P2093 "Andrew M South" @default.
- Q96120346 P2093 "J Brian Byrd" @default.
- Q96120346 P2093 "Jordana B Cohen" @default.
- Q96120346 P2093 "Julio A Chirinos" @default.
- Q96120346 P2093 "Matthew A Sparks" @default.
- Q96120346 P2093 "Swapnil Hiremath" @default.
- Q96120346 P2093 "Thomas C Hanff" @default.
- Q96120346 P2860 Q44327990 @default.
- Q96120346 P2860 Q46941804 @default.
- Q96120346 P2860 Q87799107 @default.
- Q96120346 P2860 Q90675418 @default.
- Q96120346 P2860 Q90711199 @default.
- Q96120346 P2860 Q90757948 @default.
- Q96120346 P2860 Q92015588 @default.
- Q96120346 P304 "e140-e141" @default.
- Q96120346 P31 Q13442814 @default.
- Q96120346 P356 "10.1161/CIRCRESAHA.120.317205" @default.
- Q96120346 P433 "12" @default.
- Q96120346 P478 "126" @default.
- Q96120346 P577 "2020-06-04T00:00:00Z" @default.
- Q96120346 P698 "32496917" @default.
- Q96120346 P921 Q84263196 @default.
- Q96120346 P932 "7265880" @default.